Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice history

Curis, Inc. News

Curis Shares Stabilize After Rout as Analysts Reiterate Price Targets

Curis trades higher as analysts reiterate their outlooks after the stock loses more than a third of its market value on disappointing trial results.

Curis Drops; Lower Dose of Leukemia Drug to Reach Phase 2 Study

Curis said it would take a lower dose of its leukemia treatment into Phase 2 studies after higher doses showed toxicities.

Curis Skyrockets on Positive Phase 1 Test for Lymphoma Treatment

Results showed the treatment 'provides potent and durable anti-cancer activity' for certain lymphoma patients, Curis said.

Biotech Premarket Movers: Spectrum, BioCryst, Curis

Spectrum Pharmaceuticals, BioCryst Pharmaceuticals and Curis were among the biotech stock movers in premarket trading on Thursday.

These 7 stocks under $10 are making big moves higher. Here's how to trade them now.

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Breaking News

Elon Musk Throws Dogecoin a Lifeline

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

Disney Fans Angry, Excited About New Guardians of the Galaxy Ride

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora Cannabis Slashing Weed Capacity in Profitability Push

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.

Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion

Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.